Printer Friendly
The Free Library
14,815,393 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for GenoSpectra, Inc., dated March 29, 2002.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-


Published Date:   March 29, 2002

Company Name:     GenoSpectra, Inc.

Address:          6519 Dumbarton Circle
                  Fremont, CA  94555

Main Telephone
 Number:          510/818-2628

Internet Home
 Page Address
  (URL)           www.genospectra.com

Chief Financial
 Officer:         William D. Waddill

Investor Relations
 Contact:         Victor Shi, Ph.D.
 Business number: 510/818-2624
 E-mail address:  vshi@genospectra.com

Public Relations
 Contact:         Victor Shi, Ph.D.
 Business number: 510/818-2624
 E-mail address:  vshi@genospectra.com

Industry:         Biotech


Company Description: GenoSpectra is a life science technology company based in San Francisco Bay Area “Bay Area” redirects here. For other uses, see Bay Area (disambiguation).

The San Francisco Bay Area, colloquially known as the Bay Area or The Bay
. The core of GenoSpectra's technology platform involves a novel and proprietary design employing fiber optics fiber optics, transmission of digitized messages or information by light pulses along hair-thin glass fibers. Each fiber is surrounded by a cladding having a high index of refractance so that the light is internally reflected and travels the length of the fiber  technologies. This technology allows simultaneous transfer of information and transport of materials by implementing the massive parallel processing parallel processing, the concurrent or simultaneous execution of two or more parts of a single computer program, at speeds far exceeding those of a conventional computer.  power of fiber optics for drug discovery, diagnostics and other life science applications.

GenoSpectra focuses on building a robust pipeline of products centered on its core platform. The Company will produce high-density DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 and protein microarrays that are affordable to every lab, flexible for standard and custom applications, and compatible with current installation of devices for microarray analysis. In addition, GenoSpectra will bring to the market an extreme high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method  (XHTS(TM)) system that transforms microtiter plate A Microtiter plate or microplate is a flat plate with multiple "wells" used as small test tubes. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories.  based screening into microarray scale screening. The company aims to drastically lower entry barriers to parallel drug discovery through its product offerings and a lead compound discovery program - FForward(TM) Discovery. This program integrates XHTS(TM), ADMET ADMET Acyclic Diene Metathesis
ADMET Absorption, Distribution, Metabolism, Excretion, and Toxicity (drug properties) 
 microarrays, and biomarker microarrays for parallel drug screening against target families and validation through chemical knockout.

GenoSpectra will also expand the application of its fiber optics-based technology to medical device, combinatorial chemistry and material science.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 29, 2002
Words:310
Previous Article:Corporate Profile for Select Comfort, dated March 29, 2002.
Next Article:Corporate Profile for Founders Food & Firkins Ltd. dba Granite City Food & Brewery, dated March 29, 2002.



Related Articles
KILL BW1139, PROFILE/WI-CAREQUEST.
Corporate Profile for Chronimed Inc., dated March 15, 2002.
Applications approved under Bank Holding Company Act. (Legal Developments).(Brief Article)
GenoSpectra Appoints Dr. Frank Witney Chief Executive Officer; Discovery Tools Executive to Drive Commercialization of Massively Parallel Assay...
Multimedia Available: GenoSpectra Appoints Dr. Frank Witney Chief Executive Officer.
Newstream.com Digest: Simple Heart Scan Saves Lives in the ER, Building Stadiums With Better Security and Other Free Multimedia Content for...
GenoSpectra Appoints Dr. Gary McMaster Chief Scientific Officer; Pharmaceutical Research Executive to Lead Development of Massively Parallel Assay...
Brascan Announces US$450 Million Debenture Issue.
Agilent Technologies' Venture Unit Invests in Genospectra Inc.'s Series C Round of Funding.
OMRON Healthcare Announces Dissolution of Affiliated Company.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles